Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News DRI Healthcare Trust T.DHT.UN

Alternate Symbol(s):  DHTRF

DRI Healthcare Trust is an open-ended trust that provides unitholders with differentiated exposure to the anticipated growth in the global pharmaceuticals and biotechnology markets. Its business model is focused on managing and growing a diversified portfolio of pharmaceutical royalties to deliver attractive growth in cash royalty receipts over the long term. Geographically, it has a presence... see more

Recent & Breaking News (TSX:DHT.UN)

Canadian Investment Regulatory Organization Trading Halt - DHT.UN

Canada NewsWire July 12, 2023

Canadian Investment Regulatory Organization Trade Resumption - DHT.UN

Canada NewsWire July 7, 2023

DRI Healthcare Trust Announces Acquisition of an Additional Royalty Interest in the Worldwide Sales of VONJO® (pacritinib)

Canada NewsWire July 7, 2023

Canadian Investment Regulatory Organization Trading Halt - DHT.UN

Canada NewsWire July 7, 2023

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Net Sales of Orserdu(TM) (elacestrant) and Reiterates Long-Term Cash Receipts Outlook

Canada NewsWire June 30, 2023

DRI Healthcare Trust Announces US$54.8 Million Debt Repayment from CTI BioPharma Corp.

Canada NewsWire June 26, 2023

DRI Healthcare Trust Announces Voting Results of AGM

Canada NewsWire May 12, 2023

DRI Healthcare Trust Reports First Quarter 2023 Results

Canada NewsWire May 11, 2023

DRI Healthcare Trust Announces Participation in Upcoming Investor Conferences

Canada NewsWire May 10, 2023

DRI Healthcare Trust to Host First Quarter Earnings Call and Webcast on May 12, 2023

Canada NewsWire April 27, 2023

DRI Healthcare Trust Announces Sale of its TZIELD(TM) Royalty Interest to Sanofi for US$210 Million and Announces a US$20 Million Special Cash Distribution to Unitholders

Canada NewsWire April 27, 2023

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELD(TM) (teplizumab-mzwv) and Updates Long-Term Cash Receipts Outlook

Canada NewsWire March 8, 2023

DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2022 Results

Canada NewsWire March 1, 2023

DRI Healthcare Trust to Host Fourth Quarter and Full Year 2022 Earnings Call and Webcast on March 2, 2023

Canada NewsWire February 16, 2023

DRI Healthcare Trust Announces US$95 million Private Placement of Preferred Securities and Increased Deployment Target

Canada NewsWire February 8, 2023

DRI Healthcare Trust Declares Unit Distribution and Provides Update on Normal Course Issuer Bid

Canada NewsWire December 21, 2022

DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of Xenpozyme® (olipudase alfa) for the Treatment of Acid Sphingomyelinase Deficiency

Canada NewsWire November 28, 2022

DRI Healthcare Trust Announces Appointment of Poonam Puri to Board of Trustees

Canada NewsWire November 7, 2022

DRI Healthcare Trust Reports Third Quarter 2022 Results

Canada NewsWire November 7, 2022

DRI Healthcare Trust to Host Third Quarter Earnings Call and Webcast on November 8, 2022

Canada NewsWire October 25, 2022